Antimycobacterials Flashcards

Exam 1 List

1
Q

How does Isoniazid work?

A

Unknown but thought to inhibit cell-wall biosynthesis by interfering with lipid and DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the absorption of PO Isoniazid

A

Rapid and complete absorption orally. Food slows absorption rate. Peak plasma time 1-2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Isoniazid’s distribution:

A

Distributed to all body tissues and fluids.
Can cross into CSF
Crosses placenta & enters breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe how Isoniazid is metabolized:

A

Extensively metabolized by liver. However, metabolism is largely variable and based on genetic acetylation. (A person can be slow or fast acetylator)
The rate of acetylation does not alter effectiveness but may increase the risk for toxic reactions in slow acetylators

Ex. Fast acetylators metabolize this drug five to six times faster than slow acetylators do.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is Isoniazid eliminated?

A

Undergoes half-life elimination.
Urine excretion is 75-95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Black Box Warning for Isoniazid:

A

Can cause severe and sometimes fatal hepatitis. Risk is related to age and increases with daily alcohol consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PO education for Isoniazid

A

May be taken with meals or antacids if GI irritation occurs, but do not take within 1 h of aluminum-containing antacid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common adverse reaction for Isoniazid?

A

Peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which patients are at high risk for developing peripheral neuropathy when taking Isoniazid?

A

Malnourished
Slow acetylators
Pregnant women
Older adults
Diabetics
Patients with chronic liver disease, & those with alcohol use disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What medication can be given to prevent development of peripheral neuropathy in patients taking Isoniazid?

A

Pyridoxine (B6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What foods/medications should be avoided when taking Isoniazid?

A

Alcohol, aluminum salts, oral anticoagulants, benzodiazepines, carbamazepine, cyclosporine, disulfiram, hydantoins, rifampin, theophylline, warfarin, tyramine-containing foods, histamine containing foods, ketoconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Providers should use Isoniazid cautiously and closely monitor patients who:

A

Drink alcohol daily
Have liver disease or severe renal dysfunction
Are HIV +
Are pregnant
Have preexisting peripheral neuropathy
Are older than 35 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the MOA of Rifampin

A

Inhibits RNA synthesis/transcription by binding to the beta subunit of RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the PO absorption of Rifampin:

A

Well absorbed; food may delay or slightly reduce peak. Peak plasma time 2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do organisms develop resistance to Rifampin?

A

Point mutations that prevent binding to RNA polymerase; organisms develop this mutation rapidly when Rifampin is used as a monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do organisms develop resistance to Isoniazid?

A

Through inhA gene or deletion of katG gene which encodes mycobacterium catalase

17
Q

How is Rifampin metabolized?

A

Metabolized by the liver and undergoes enterohepatic recirculation.
Half life: 3-4 hours (prolonged in hepatic impairment)

18
Q

Describe the distribution of Rifampin:

A

Highly lipophilic: penetrate and concentrate in most body fluids.
Crosses the blood brain barrier, as well as the placenta, and enters breast milk

19
Q

How is Rifampin eliminated?

A

Mainly in bile
The rest in feces through enterohepatic recirculation, and a small amount in urine

20
Q

Precautions & Considerations for Rifampin:

A

Use cautiously in hepatic impairment
Rifampin is a potent inducer of liver metabolism and can lead to sub therapeutic concentrations of other drugs metabolized by CYP enzymes

21
Q

What drugs/medications should be avoided when taking Rifampin?

A

Digoxin, Isoniazid, oral anticoagulants, azole antifungals, barbiturates, BDZs, beta blockers, chloramphenicol, clofibrate, oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, efavirenz, elvitegravir, etravirine, estrogens, hydantoins, methadone, mexiletine, miraviroc, nevirapine, quinidine, sildenafil, sulfonylureas, tacrolimus, tamoxifen, theophylline, tocainide, verapamil

22
Q

Patients taking Isoniazid tend to have an elevation in these labs:

A

Elevated serum transaminases (AST/ALT) are observed in 10% to 20% of patients

23
Q

Common adverse reactions associated with Rifampin:

A

-GI: anorexia, nausea, vomiting, diarrhea, flatulence, and abdominal pain.
-Hepatotoxicity leading to hepatitis
-Transient elevations of AST/ALT in the first 8 weeks of therapy
-Orange-red discoloration of body fluids,

24
Q

How does Rifampin interact with other drugs that undergo hepatic metabolism?

A

Rifampin is a potent inducers of the CYP enzyme system and speed the metabolism of many drugs, resulting in therapeutic failure.

25
Q

Absorption & Distribution of Pyrazinamide:

A

Well absorbed
Widely distributed into body tissues and fluids including liver, lung, and CSF. Crosses the placenta, and enters breast milk

26
Q

Metabolism & Excretion of Pyrazinamide:

A

Half life: 9-10 hour
70% Hydrolyzed by the liver & excreted in urine by glomerular filtration

27
Q

Resistance to Pyrazinamide:

A

Resistance develops rapidly when used as monotherapy

28
Q

Metabolically, what happens to Pyrazinamide in the presence of impaired renal or hepatic function?

A

Its half-life may be significantly prolonged

29
Q

What comorbidity is considered high risk for patients taking Pyrazinamide?

A

hepatic impairment

30
Q

Pyrazinamide has been known to interact with which lab tests?

A

Acetest and Ketostix urine tests to determine ketoacidosis

31
Q

Adverse reactions for Pyrazinamide:

A

Dose-related hepatotoxicity
Hyperuricemia

32
Q

Adverse reactions for Ethambutol:

A

Optic neuritis

33
Q

Signs/Symptoms of optic neuritis r/t Ethambutol:

A

Decreased visual acuity, red–green color blindness, diminished visual fields, and sometimes loss of vision

34
Q

What food/drugs should be avoided when taking Ethambutol?

A

Aluminum salts as they reduce the absorption of ethambutol

35
Q

Metabolism & Excretion of Ethambutol:

A

20%-50% metabolized by oxidation in the liver
Half life: 2.5-3.6 hours
Prolonged in ESRD

50% excreted via urine as unchanged drug

36
Q

What is the mechanism of action of ethambutol?

A

Interferes with the synthesis of arabinogalactan, an essential component of mycobacterial cell walls

37
Q

Absorption & Distribution for Ethambutol:

A

Bioavailability ~80%
Peak plasma time 2-4 hours

Widely distributed throughout body
Crosses into CSF with inflamed meninges

38
Q

ethambutol should be used cautiously in patients with:

A

renal impairment
Patients who are unable to appreciate or report visual changes or who have preexisting optic neuritis, cataracts, or diabetic retinopathy.

39
Q

Adverse drug effects of ethambutol:

A

Visual disturbances, including irreversible blindness